(Press-News.org) Richmond, Va. (June 15, 2012) – A multi-institutional research study has uncovered a new mechanism that may lead to unique treatments for lung cancer, one of the leading causes of death worldwide.
The study recently published in the journal Genes & Development was a collaboration between Sanford-Burnham Medical Research Institute, Virginia Commonwealth University (VCU) Massey Cancer Center and the VCU Institute of Molecular Medicine, the University of California, San Diego, the University of Minnesota and St. Jude Children's Research Hospital. The scientists discovered that the protein Bax Inhibitor-1 (BI-1) protects lung cancer cells and promotes tumor growth by regulating autophagy, a complex process initiated under stressful conditions that breaks down a cell's own components to provide nutrients needed for survival.
"Cancer cells are remarkably adaptive and depend on a variety of mechanisms to ensure their survival and continued growth when challenged by their environment," says John C. Reed, M.D., Ph.D., professor and CEO of Sanford-Burnham. "By reducing levels of BI-1, it appears we were able to modulate intracellular signals and starve lung cancer cells of the energy needed to carry out one of their most important survival mechanisms, autophagy."
The researchers showed that BI-1 appeared to be linked to levels of calcium, which aids in signal transduction. Suppressing BI-1 reduced calcium levels in the endoplasmic reticulum, the interconnected network of sacs and tubules that manufacture, process and transport a variety of compounds for use inside and outside of cells. Lowering BI-1 levels led to reduced mitochondrial activity, oxygen consumption and adenosine triphosphate (ATP) levels. ATP is often called the "molecular unit of currency" due to the important role it plays in transporting chemical energy needed for metabolism.
The researchers' laboratory findings were confirmed by animal models that showed BI-1 suppression reduced human lung cancer tumor growth.
"These studies are the first to show that BI-1 may play an important survival role in cells under circumstances where oxygen and nutrient deprivation are encountered, such as the conditions that arise in advanced tumors or when cells are stressed by chemotherapy treatments," says Paul B. Fisher, M.Ph., Ph.D., Thelma Newmeyer Corman Endowed Chair in Cancer Research and program co-leader of Cancer Molecular Genetics at VCU Massey Cancer Center, chairman of VCU's Department of Human and Molecular Genetics and director of the VCU Institute of Molecular Medicine. "We are excited by our findings because they uncover a new pathway that may be an effective target for future therapies to treat advanced lung cancer."
Next, the scientists hope to apply their findings to screen for potential drugs that can reduce BI-1-mediated protective autophagy in cancer cells.
###
Reed and Fisher collaborated with lead author Renata Sano, Ph.D., from Sanford-Burnham; Michael Hedvat, Ph.D., a VCU and Sanford-Burnham postdoctoral scholar working in Reed's laboratory; Shu-Ichi Matsuzawa, Ph.D., Russell Dahl, Ph.D., Ying-Chen Claire Hou, Ph.D., Ricardo G. Correa, Ph.D., Chih-Wen Shu, Ph.D., Maryla Krajewska, M.D., and Paul W. Diaz, Ph.D., from Sanford-Burnham; Giovanni Quarato, Ph.D., and Roberta A. Gottlieb, M.D., from San Diego State University; Masaya Yamaguchi, Ph.D., and Victor Nizet, M.D., from the University of California, San Diego; David D. Thomas, Ph.D., from University of Minnesota; and Stephen W. Tait, Ph.D., and Douglas R. Green, Ph.D., from St. Jude Children's Hospital.
This study was supported by NIH grant AG-15393, the Tobacco-Related Disease Research Foundation and an inter-institutional agreement between the Sanford-Burnham Medical Research Institute and VCU School of Medicine through a visiting professorship at Sanford-Burnham Medical Research Institute held by Fisher and support provided to Dr. Hedvat. It was also supported, in part, with funding from VCU Massey Cancer Center's NIH-NCI Cancer Center Support Grant P30 CA016059.
The full manuscript of this study is available online at:
http://genesdev.cshlp.org/content/26/10/1041.full.
News directors: Broadcast access to VCU Massey Cancer Center experts is available through VideoLink ReadyCam. ReadyCam transmits video and audio via fiber optics through a system that is routed to your newsroom. To schedule a live or taped interview, contact John Wallace, (804) 628-1550.
About VCU Massey Cancer Center
VCU Massey Cancer Center is one of only 66 National Cancer Institute-designated institutions in the country that leads and shapes America's cancer research efforts. Working with all kinds of cancers, the Center conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. It has one of the largest offerings of clinical trials in Virginia and serves patients in Richmond and in four satellite locations. Its 1,000 researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately to cure cancer. Visit Massey online at www.massey.vcu.edu or call 877-4-MASSEY for more information.
About VCU and the VCU Medical Center
Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located in downtown Richmond, VCU enrolls more than 31,000 students in 222 degree and certificate programs in the arts, sciences and humanities. Sixty-six of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see http://www.vcu.edu.
About Sanford-Burnham Medical Research Institute
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. The Institute consistently ranks among the top five organizations worldwide for its scientific impact in the fields of biology and biochemistry (defined by citations per publication) and currently ranks third in the nation in NIH funding among all laboratory-based research institutes. Sanford-Burnham is a highly innovative organization, currently ranking second nationally among all organizations in capital efficiency of generating patents, defined by the number of patents issued per grant dollars awarded, according to government statistics.
Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a U.S.-based, non-profit public benefit corporation, with operations in San Diego (La Jolla), California and Orlando (Lake Nona) in Florida. For more information, please visit our website (http://www.sanfordburnham.org) or blog (http://www.beaker.sanfordburnham.org). You can also receive updates by following us on Facebook and Twitter.
Scientists discover mechanism that promotes lung cancer growth and survival
2012-06-19
ELSE PRESS RELEASES FROM THIS DATE:
Nature inspires new submarine design
2012-06-19
Superhydrophobicity is one of most important interfacial properties between solids and liquids. SHI Yanlong and his group from the College of Chemistry and Chemical Engineering, Key laboratory of Hexi Corridor Resources Utilization of Gansu Universities, Hexi University investigated the superhydrophobicity of the water boatman's hind wings. The study showed that superhydrophobicity plays a crucial role in the water boatman's swimming, balance, and breathing in water, and in its escape ability from water area under unfavorable conditions. Their work, entitled "Investigation ...
Freud's theory of unconscious conflict linked to anxiety symptoms in new U-M brain research
2012-06-19
An experiment that Sigmund Freud could never have imagined 100 years ago may help lend scientific support for one of his key theories, and help connect it with current neuroscience.
Today at the 101st Annual Meeting of the American Psychoanalytic Association, a University of Michigan professor who has spent decades applying scientific methods to the study of psychoanalysis will present new data supporting a causal link between the psychoanalytic concept known as unconscious conflict, and the conscious symptoms experienced by people with anxiety disorders such as phobias. ...
UNU-IHDP and UNEP launch sustainability index that looks beyond GDP
2012-06-19
Rio, 17 June 2012 – The world's fixation on economic growth ignores a rapid and largely irreversible depletion of natural resources that will seriously harm future generations, according to a report which today unveiled a new indicator aimed at encouraging sustainability - the Inclusive Wealth Index (IWI).
The IWI, which looks beyond the traditional economic and development yardsticks of Gross Domestic Product (GDP) and the Human Development Index (HDI) to include a full range of assets such as manufactured, human and natural capital, shows governments the true state ...
The most contaminated surfaces in hotel rooms
2012-06-19
An experiment of surfaces in hotel rooms finds television remotes to be among the most heavily contaminated with bacteria and items on housekeeping carts carry the potential to cross-contaminate rooms. Researchers from the University of Houston report the findings today at the 2012 General Meeting of the American Society for Microbiology.
"Hoteliers have an obligation to provide their guests with a safe and secure environment. Currently, housekeeping practices vary across brands and properties with little or no standardization industry wide. The current validation ...
Intestinal bacteria produce neurotransmitter, could play role in inflammation
2012-06-19
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified commensal bacteria in the human intestine that produce a neurotransmitter that may play a role in preventing or treating inflammatory bowel diseases such as Crohn's disease.
"We identified, to our knowledge, the first bifidobacterial strain, Bifidobacterium dentium, that is capable of secreting large amounts of gamma-aminobutyric acid (GABA). This molecule is a major inhibitory neurotransmitter in the central and enteric nervous systems," says Karina Pokusaeva, a researcher on the ...
Lariats: How RNA splicing decisions are made
2012-06-19
PROVIDENCE, R.I. [Brown University] — Tiny, transient loops of genetic material, detected and studied by the hundreds for the first time at Brown University, are providing new insights into how the body transcribes DNA and splices (or missplices) those transcripts into the instructions needed for making proteins.
The lasso-shaped genetic snippets — they are called lariats — that the Brown team reports studying in the June 17 edition of Nature Structural & Molecular Biology are byproducts of gene transcription. Until now scientists had found fewer than 100 lariats, mostly ...
New Autism Treatment Website Offers Online Autism Seminars "On Demand" From World Renowned Biomedical Autism Doctor
2012-06-19
As a caregiver of a child on the autism spectrum, it's imperative to educate yourself on all available treatments and therapies, but finding the time and money to travel to and attend autism seminars and conferences can be a challenge--and in some cases, simply impossible.
Dr. Kurt Woeller is a biomedical autism treatment and recovery specialist, author and guest speaker at autism conferences and seminars throughout the United States. He understands that attendance at these conferences and seminars are limited to those with the time and the resources to attend--a very ...
Manipulation of a specific neural circuit buried in complicated brain networks in primates
2012-06-19
The collaborative research team led by Professor Tadashi ISA, Project Assistant Professor Masaharu KINOSHITA from The National Institute for Physiological Sciences, The National Institutes of Natural Sciences and Fukushima Medical University and Kyoto University, developed "the double viral vector transfection technique" which can deliver genes to a specific neural circuit by combining two new kinds of gene transfer vectors. With this method, they found that "indirect pathways", which were suspected to have been left behind when the direct connection from the brain to motor ...
Ending refugees' exile
2012-06-19
We all tend to assume that refugees want to go home. But often refugees cannot just return to their home country when conflict ends. Many have spent decades in exile; many second and third-generation refugees have never seen the place which they are now expected to call home. Research funded by the Economic and Social Research Council (ESRC) shows that for many refugees a quick return isn't the right answer.
Dr Katy Long at the London School of Economics says: "There is usually political pressure to start organising refugee returns as soon as there's a possibility of ...
Camille Matthews and Quincy Moves to the Desert Take a Virtual Book Tour with Walker Author Tours
2012-06-19
Walker Author Tours, a company that brings new authors to the attention of the reading public through online, virtual book tours, is pleased to announce the two-week book blog tour for Camille Matthews's second Quincy novel, Quincy Moves to the Desert. This book tour will include tour stops at a variety of book blogs on the Internet where readers may read reviews, author interviews, and ask questions of the author as well as a webcast radio spot with a live interview with Ms. Matthews.
The Quincy Moves to the Desert book tour will run June 18 through 29, 2012. This ...